Integrated Filing-Governance



General information about company

Scrip Code 539787
NSE Symbol HCG
MSEI Symbol NOTLISTED
ISIN INE075I01017
Name of the entity Healthcare Global Enterprises Limited
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Reporting Quarter Quarterly
Date of Quarter Ending 31-Dec-2024
Type of company Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? Yes
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? No
Reason For Part D Of Annexure I Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity There are no fines/penalties imposed by regulatory, statutory, enforcement authority or judicial body against the listed entity or its directors, key managerial personnel, senior management, promoter or subsidiary, in relation to the listed entity.
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? No
Reason For Part E Of Annexure I Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Not Applicable To The Entity There are no material litigations or disputes, the outcome thereof may have an impact on the listed entity.
Risk management committee
Market Capitalisation as per immediate previous Financial Year Top 1000 listed entities
Is SCORE ID Available ? Yes
SCORE Registration ID hoo392
Reason For No SCORE ID
Type of Submission Original
Remarks (website dissemination)



Annexure I
Annexure I to be submitted by listed entity on quarterly basis
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory 1. Geeta Mathur has resigned as an Independent Director of Onmobile Global Limited on 31 December 2024. For the purpose of the Corporate Governance Report for the quarter ended on 31 December 2024, her Directorship in Onmobile Global Limited and memberhsip/Chairmanship is included. 2. Jeyandran Venugopal has resigned as an Independent Director of the Company (HealthCare Global Enterprises Limited) with effect from the close of business hours on November 09, 2024.
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO No Disqualification of Directors under section 164 of the Companies Act, 2013
Sr Title (Mr / Ms) Name of the Director PAN DIN Category 1 of directors Category 2 of directors Category 3 of directors Date of Birth Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of appointment Date of Re-appointment Date of cessation Tenure of director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)] Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
1 Mr. Basavalinga Sadashivaiah Ajaikumar 00713779 Executive Director Chairperson 22-Aug-1951 No Active NA 07-Mar-2000 1 0 1 0
2 Mr. Amit Soni 05111144 Non-Executive - Nominee Director Not Applicable 28-Jan-1980 No Active NA 28-Jul-2020 1 0 1 1
3 Mr. Siddharth Tapaswin Patel 07803802 Non-Executive - Nominee Director Not Applicable 30-Jun-1977 No Active NA 28-Jul-2020 1 0 0 0
4 Mrs. Anjali Ajaikumar Rossi 08057112 Executive Director Not Applicable 07-May-1986 No Active NA 01-Apr-2021 1 0 0 0
5 Mrs. Geeta Mathur 02139552 Non-Executive - Independent Director Not Applicable 21-Nov-1966 No Active NA 17-Jun-2021 17-Jun-2024 42.14 5 5 8 5
6 Mr. Rajagopalan Raghavan 03627923 Non-Executive - Independent Director Not Applicable 28-Jun-1964 No Active NA 12-Aug-2021 12-Aug-2024 40.19 1 1 2 1
7 Mr. Jeyandran Venugopal 07085479 Non-Executive - Independent Director Not Applicable 25-Apr-1977 No Active NA 11-Nov-2021 09-Nov-2024 35.28 1 1 0 0
8 Mr. Pradip Manilal Kanakia 00770347 Non-Executive - Independent Director Not Applicable 04-Jun-1960 No Active NA 10-Feb-2022 10-Feb-2022 34.21 6 6 4 7
9 Mr. Meghraj Arvindrao Gore 07505123 Executive Director Not Applicable 01-Jan-1975 No Active NA 10-Feb-2022 10-Feb-2022 1 0 0 0
10 Mr. Rajiv Maliwal 00869035 Non-Executive - Independent Director Not Applicable 26-Nov-1960 No Active NA 25-May-2023 25-May-2023 19.05 1 1 0 0



Annexure 1

II. Composition of Committees
Disclosure of notes on composition of committees explanatory



Audit Committee Details
Whether the Audit Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 02139552 Geeta Mathur Non-Executive - Independent Director Chairperson 11-Nov-2021
2 05111144 Amit Soni Non-Executive - Nominee Director Member 28-Jul-2020
3 03627923 Rajagopalan Raghavan Non-Executive - Independent Director Member 21-Dec-2021
4 00770347 Pradip Manilal Kanakia Non-Executive - Independent Director Member 26-May-2022



Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 03627923 Rajagopalan Raghavan Non-Executive - Independent Director Chairperson 11-Nov-2021
2 00713779 Basavalinga Sadashivaiah Ajaikumar Executive Director Member 01-Apr-2021
3 07803802 Siddharth Tapaswin Patel Non-Executive - Nominee Director Member 28-Jul-2020
4 02139552 Geeta Mathur Non-Executive - Independent Director Member 29-Dec-2021
5 07085479 Jeyandran Venugopal Non-Executive - Independent Director Member 29-Dec-2021 09-Nov-2024
6 00869035 Rajiv Maliwal Non-Executive - Independent Director Member 10-Aug-2023
7 00770347 Pradip Manilal Kanakia Non-Executive - Independent Director Member 31-Dec-2024



Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 05111144 Amit Soni Non-Executive - Nominee Director Chairperson 28-Jul-2020
2 00713779 Basavalinga Sadashivaiah Ajaikumar Executive Director Member 29-May-2015
3 03627923 Rajagopalan Raghavan Non-Executive - Independent Director Member 28-Jun-2023



Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00713779 Basavalinga Sadashivaiah Ajaikumar Executive Director Chairperson 17-Jun-2021
2 07505123 Meghraj Arvindrao Gore Executive Director Member 17-Jun-2021
3 00770347 Pradip Manilal Kanakia Non-Executive - Independent Director Member 08-Feb-2024



Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Notes for not providing Date Whether requirement of Quorum met (Yes/No) Total Number of Directors as on date of the meeting Number of Directors present* (All directors including Independent Director) No. of Independent Directors attending the meeting*
1 02-Jul-2024 Yes 10 5 2
2 08-Aug-2024 36 Yes 10 9 4
3 09-Nov-2024 92 Yes 10 9 4



Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr Name of Committee Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Name of other committee Reson for not providing date Whether requirement of Quorum met (Yes/No) Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All Directors including Independent Director) No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1 Audit Committee 08-Aug-2024 Yes 4 2 2 0
2 Audit Committee 09-Nov-2024 92 Yes 4 2 2 0
3 Nomination and remuneration committee 07-Aug-2024 Yes 6 4 2 0
4 Nomination and remuneration committee 09-Nov-2024 93 Yes 6 5 3 0
5 Risk Management Committee 16-May-2024 Yes 3 3 1 0
6 Risk Management Committee 21-Nov-2024 188 Yes 3 3 1 0



Annexure 1
VI. Affirmations
Sr Subject Compliance status (Yes/No)
1 The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
2 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee Yes
3 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee Yes
4 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee Yes
5 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) Yes
6 The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. Yes
7 The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
8 This report and/or the report submitted in the previous quarter has been placed before Board of Directors. Yes
9 Any comments/observations/advice of Board of Directors may be mentioned here:



Annexure 1
Sr Subject Compliance status
1 Name of signatory Sunu Manuel
2 Designation Company Secretary and Compliance Officer



Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter No
Other details of cyber security incidence or breaches or loss of data event
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr Date of the event Brief details of the event



Signatory Details
Name of signatory Sunu Manuel
Designation of person Company Secretary and Compliance Officer
Place Bengaluru
Date 17-Jan-2025


Investor Grievance Details
No. of investor complaints pending at the beginning of Quarter 0
No. of investor complaints received during the Quarter 0
No. of investor complaints disposed off during the Quarter 0
No. of investor complaints those remaining unresolved at the end of the Quarter 0


Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies-
The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below
Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies
Sr. No. Name of the unlisted company in which shares or voting rights have been acquired Date of acquisition Aggregate holding (% shares or voting rights) as at the end of the previous quarter % shares or voting rights acquired during the quarter Aggregate holding (% shares or voting rights) as at the end of the quarter
1 Vizag Hospital and Cancer Research Centre Pvt Ltd 02-Oct-2024 0 51.00 51.00


Disclosure of Imposition of Fine or Penalty
The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:
Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No. Name of the authority Nature and details of the action(s) taken or order(s) passed Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority Details of the violation(s)/ contravention(s) committed or alleged to be committed Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible


Disclosure of Updates to Ongoing Tax Litigations or Disputes
The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below:

Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes
Sr. No. Name of the opposing party Date of initiation of the litigation / dispute Status of the litigation / dispute as per last disclosure Current status of the litigation / dispute